STOML2 anticorps

N° du produit ABIN7255297

Cet anticorps anti-STOML2 est un anticorps Polyclonal produit chez le Lapin, détectant STOML2 dans IHC. Convient pour Humain, Souris et Rat.

Aperçu rapide pour STOML2 anticorps (ABIN7255297)

Antigène: STOML2 (Stomatin (EPB72)-Like 2 (STOML2))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp STOML2 est non-conjugé

Application: Immunohistochemistry (IHC)

Détail du produit anti-STOML2 anticorps

Attributs du produit: Polyclonal Antibody

Purification: Affinity purification

Immunogène: Recombinant fusion protein of human STOML2 (NP_038470.1).

Isotype: IgG

Information d'application

Indications d'application: IHC 1:50-1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur STOML2

Antigène: STOML2 (Stomatin (EPB72)-Like 2 (STOML2))

Autre désignation: STOML2

Sujet: Human stomatin (band 7.2b) is a 31- kDa erythrocyte membrane protein of unknown function but implicated in the control of ion channel permeability,mechanoreception,and lipid domain organization. Stomatin (EPB72)-like 2 (STOML2,synonyms: SLP-2,HSPC108) is a 38.5- kDa protein that is overall approximately 20 % similar to human stomatin. STOML2 is also present in mature human erythrocytes ,but lacks a characteristic NH(2)-terminal hydrophobic domain found in other stomatin homologues. STOML2 may link stomatin or other integral membrane proteins to the peripheral cytoskeleton and thereby play a role in regulating ion channel conductances or the organization of sphingolipid and cholesterol-rich lipid rafts.

ID gène: 30968

UniProt: Q9UJZ1

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2